youtube_live
Q3 2026 earnings • released • EPS miss -29.02% • Revenue beat +5.62%
See resultschevron_right
TNXP:NASDAQ
Tonix Pharmaceuticals Holding Corp
US$3.01
arrow_downward
-7.10%(-0.23) 1D
US$3.06
arrow_upward
+1.66% (+0.050)bedtimeAfter hours
Closed: ኖቬም 13, 4:00:00 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TNXP...
Open
US$3.25
High
US$3.25
Low
US$2.90
Mkt. cap
58.49 ሚ
Avg. vol.
1.12 ሚ
Volume
1.94 ሚ
52-wk high
US$20.56
52-wk low
US$2.90
EPS
-US$12.92
Beta
1.90
Shares outstanding
19.43 ሚ
No. of employees
142
Open
US$3.25
High
US$3.25
Low
US$2.90
Mkt. cap
58.49 ሚ
Avg. vol.
1.12 ሚ
Volume
1.94 ሚ
52-wk high
US$20.56
52-wk low
US$2.90
EPS
-US$12.92
Beta
1.90
Shares outstanding
19.43 ሚ
No. of employees
142
News stories
From web sources and news partners
Yahoo Finance
·
ከ2 ቀናት በፊት
Tonix Pharmaceuticals (TNXP) Stock Fair Value Falls As Analysts Weigh Tonmya And Funding Risk
Yahoo Finance
·
ከ3 ቀናት በፊት
Tonix Pharmaceuticals’ TONMYA Sales Jump 37% as Insurance Coverage Expands
Profile
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. Wikipedia
About Tonix Pharmaceuticals Holding Corp
CEOSeth Lederman
Employees142
Founded2007
HeadquartersBerkeley Heights, ኒው ጄርዚ, ዩናይትድ ስቴትስ
SectorHealth Care
IndustryBiotechnology
Websitetonixpharma.com